DUBLIN, Feb. 16, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced the publication of a new manuscript presenting real-world evidence on treatment patterns for patients with plantar fibromatosis ...

Plantar fibromatosis, commonly referred to as Ledderhose disease, is a benign yet locally aggressive proliferation of fibroblasts and collagen within the plantar fascia. Clinically, it presents as ...

Plantar Fasciitis: Symptoms, Causes, Diagnosis and Treatment: By Shreoshree Chakrabarty Plantar Fasciitis is a common and painful foot condition that impacts millions globally, often affecting daily ...

Previously unpublished clinical data support the potential long‑term safety and efficacy of collagenase clostridium histolyticum (CCH) for plantar fibromatosis. The findings will be presented at the ...

MALVERN, Pa., July 24, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that three presentations related to plantar fibromatosis (PFI) and plantar fasciitis (PFA) will be shared during ...

Treatment with CCH led to a clinically meaningful and statistically significant reduction in daily foot pain at week 12 compared with placebo. Topline data were announced from a phase 3 trial ...

Plantar fibromatosis is a progressive condition with no FDA-approved nonsurgical treatment options. With no official treatment guidelines available, Keenova and its clinical partners are working to ...